SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB)
NCT00879008
·
clinicaltrials.gov ↗
COMPLETED
Status
345
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Bronchitis
Interventions
DRUG:
Moxifloxacin (Avelox, BAY12-8039)
Sponsor
Bayer